ATE75399T1 - Therapeutikum zur behandlung von magengeschwueren. - Google Patents

Therapeutikum zur behandlung von magengeschwueren.

Info

Publication number
ATE75399T1
ATE75399T1 AT87114328T AT87114328T ATE75399T1 AT E75399 T1 ATE75399 T1 AT E75399T1 AT 87114328 T AT87114328 T AT 87114328T AT 87114328 T AT87114328 T AT 87114328T AT E75399 T1 ATE75399 T1 AT E75399T1
Authority
AT
Austria
Prior art keywords
treatment
therapeutic
stomach ulcers
oxohexyl
oxopentyl
Prior art date
Application number
AT87114328T
Other languages
English (en)
Inventor
Masao Sakurai
Masayoshi Goto
Toshizo Tanaka
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Application granted granted Critical
Publication of ATE75399T1 publication Critical patent/ATE75399T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT87114328T 1986-10-06 1987-10-01 Therapeutikum zur behandlung von magengeschwueren. ATE75399T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23607886 1986-10-06
EP87114328A EP0266559B1 (de) 1986-10-06 1987-10-01 Therapeutikum zur Behandlung von Magengeschwüren

Publications (1)

Publication Number Publication Date
ATE75399T1 true ATE75399T1 (de) 1992-05-15

Family

ID=16995393

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87114328T ATE75399T1 (de) 1986-10-06 1987-10-01 Therapeutikum zur behandlung von magengeschwueren.

Country Status (16)

Country Link
US (1) US4845102A (de)
EP (1) EP0266559B1 (de)
JP (1) JPS63225317A (de)
KR (1) KR950007101B1 (de)
AT (1) ATE75399T1 (de)
AU (1) AU595379B2 (de)
CA (1) CA1297021C (de)
DE (1) DE3778642D1 (de)
DK (1) DK169305B1 (de)
ES (1) ES2032797T3 (de)
GR (1) GR3004848T3 (de)
HU (1) HU200098B (de)
IE (1) IE60863B1 (de)
IL (1) IL84096A (de)
PT (1) PT85866B (de)
ZA (1) ZA877454B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤
DD298051A5 (de) * 1989-08-16 1992-02-06 ��@���������@�������k�� Verfahren zur herstellung eines therapeutischen agens zur behandlung von verdauungskrankheiten
DE4025371A1 (de) * 1990-08-10 1992-02-13 Kali & Salz Ag Verfahren zur reinigung von elektrostatisch gewonnenem steinsalz
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US5780476A (en) * 1992-11-16 1998-07-14 Cell Therapeutics, Inc. Hydroxyl-containing xanthine compounds
US6693105B1 (en) 1992-11-16 2004-02-17 Cell Therapeutics, Inc. Hydroxyl-containing compounds
US20030207901A1 (en) * 1999-07-27 2003-11-06 Cell Therapeutics, Inc. Hydroxyl-containing compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2330742C2 (de) * 1973-06-16 1982-07-29 Hoechst Ag, 6000 Frankfurt 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
CH608236A5 (de) * 1974-01-22 1978-12-29 Wuelfing J A Fa
CA1075690A (en) * 1974-12-13 1980-04-15 Hoechst Aktiengesellschaft Xanthine derivatives
US4511557A (en) * 1981-08-24 1985-04-16 Gauri Kailash Kumar Pharmaceutical composition
IT1200944B (it) * 1982-08-10 1989-01-27 Malesci Sas Derivati xantinici,procedimento per la loro preparazione,composizione farmaceutiche che il contengono e loro impiego terapeutico
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement

Also Published As

Publication number Publication date
DK169305B1 (da) 1994-10-10
GR3004848T3 (de) 1993-04-28
ES2032797T3 (es) 1993-03-01
IE872656L (en) 1988-04-06
IL84096A (en) 1991-07-18
IL84096A0 (en) 1988-03-31
JPS63225317A (ja) 1988-09-20
DE3778642D1 (de) 1992-06-04
KR950007101B1 (ko) 1995-06-30
EP0266559A2 (de) 1988-05-11
IE60863B1 (en) 1994-08-24
PT85866A (en) 1987-11-01
EP0266559B1 (de) 1992-04-29
AU595379B2 (en) 1990-03-29
DK520787A (da) 1988-04-07
CA1297021C (en) 1992-03-10
EP0266559A3 (en) 1990-06-06
KR880004810A (ko) 1988-06-27
HUT46214A (en) 1988-10-28
ZA877454B (en) 1988-05-25
DK520787D0 (da) 1987-10-05
PT85866B (pt) 1990-07-31
US4845102A (en) 1989-07-04
AU7935887A (en) 1988-04-14
HU200098B (en) 1990-04-28

Similar Documents

Publication Publication Date Title
PL262105A1 (en) The method of manufacture of new derivatives of benzimidazole
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
DE3788057T2 (de) Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen.
NO871295D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO871588D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
NO870049L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
ATE70182T1 (de) Therapeutische mittel zur behandlung von magengeschwueren.
DE69419954T2 (de) Arzneimittel zur Behandlung von Hauterkrankungen
DE68921051D1 (de) Pyridin-3-percarboxylsäure monopersulfat.
DE69029069D1 (de) Verwendung von Xanthinderivaten gegen Magengeschwüre
KR900016130A (ko) 2-피리딜메틸티오 유도체 및 궤양 치료제
ES8106156A1 (es) Un procedimiento para la preparacion de derivados de oxadia-zolotriazona
NO821083L (no) Fremgangsmaate for fremstilling av terapeutisk aktive morfantridin-derivater
NO890245L (no) Isoxazoler med nootrop aktivitet.
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
PT87077A (pt) Terc-butylamino-3-(phenyl-2:-phenoxy)-1-propanol-2 and its acid addition salts for use as an active therapeutic substance
NO870499D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
DE3674060D1 (de) Pharmacologisch aktive propionylanilide.